Recent Developments in A2B Adenosine Receptor Ligands
- Author
- KALLA, Rao V1 ; ZABLOCKI, Jeff; AGHAZADEH TABRIZI, Mojgan; GIOVANNI BARALDI, Pier
[1] Department of Medicinal Chemistry, CV Therapeutics Inc., 3172 Porter Drive, Palo Alto, CA 94304, United States - Issue title
- Adenosine Receptors in Health and Disease
- Author (monograph)
- WILSON, Constance N (Editor)1 ; MUSTAFA, S. Jamal (Editor)2
[1] Endacea, Inc., P. O. Box 12076 (Mail), 2 Davis Drive (Courier), Research Triangle Park, NC 27709-2076, United States
[2] Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV 26505-9229, United States - Source
Handbook of experimental pharmacology. 2009, Vol 193, pp 99-122, 24 p ; ref : 2 p.3/4
- ISSN
- 0171-2004
- Scientific domain
- Pharmacology drugs
- Publisher
- Springer, Heidelberg
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Adenosine receptor antagonist Asthma CVT-6883 LAS-38096 MRE2029F20
- Keyword (fr)
- Activité biologique Antagoniste Article synthèse Asthme Essai clinique phase I Etude expérimentale Ligand Modèle animal Mécanisme action Recherche et développement Récepteur adénosinique A2B Récepteur adénosinique Souris CVT-6883 Bronchopneumopathie obstructive Mammalia Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Rodentia Vertebrata
- Keyword (en)
- Biological activity Antagonist Review Asthma Phase I trial Experimental study Ligand Animal model Mechanism of action Research and development A2B adenosine receptor Adenosine receptor Mouse Obstructive pulmonary disease Mammalia Respiratory disease Bronchus disease Lung disease Rodentia Vertebrata
- Keyword (es)
- Actividad biológica Antagonista Artículo síntesis Asma Ensayo clínico fase I Estudio experimental Ligando Modelo animal Mecanismo acción Investigación desarrollo Receptor adenosínico A2B Receptor adenosínico Ratón Enfermedad pulmonar obstructiva Mammalia Aparato respiratorio patología Bronquio patología Pulmón patología Rodentia Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A03 Pharmaceutical technology. Pharmaceutical industry
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11B Chronic obstructive pulmonary disease, asthma
- Discipline
- General pharmacology Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21939494
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/978-3-540-89615-9_4 
https://dx.doi.org/10.1007/978-3-540-89615-9_4
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"122\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KALLA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rao V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"ZABLOCKI, Jeff\";i:1;s:25:\"AGHAZADEH TABRIZI, Mojgan\";i:2;s:22:\"GIOVANNI BARALDI, Pier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"24\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"122\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KALLA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rao V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"ZABLOCKI, Jeff\";i:1;s:25:\"AGHAZADEH TABRIZI, Mojgan\";i:2;s:22:\"GIOVANNI BARALDI, Pier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"24\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_4\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"122\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KALLA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rao V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"ZABLOCKI, Jeff\";i:1;s:25:\"AGHAZADEH TABRIZI, Mojgan\";i:2;s:22:\"GIOVANNI BARALDI, Pier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"24\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"122\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KALLA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rao V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"ZABLOCKI, Jeff\";i:1;s:25:\"AGHAZADEH TABRIZI, Mojgan\";i:2;s:22:\"GIOVANNI BARALDI, Pier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:53:\"Recent Developments in A2B Adenosine Receptor Ligands\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"24\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
